CIK 1596452
Long positions in SEC Section 13(f) securities (US-listed stocks, ADRs and ETFs), largest first · Δ vs 2025-Q4. A lagged quarterly snapshot (filed ≤45 days after quarter-end); excludes shorts, options, cash, and shares listed only on non-US exchanges — foreign companies held via a US listing or ADR (e.g. Alibaba, TSMC) ARE included.
As filed = each book applied at its quarter-end (what the reported book did) · As copyable = applied at its statutory 45-day filing deadline (what a 13F follower could have earned).
Computing…
Hypothetical modeled performance constructed with hindsight — not actual results, and not indicative of future results. See the Disclaimer.
| Industry group | Weight | Names |
|---|---|---|
| Pharmaceuticals & Biotechnology | 28.75% | 10 |
| Unclassified | 18.36% | 2 |
| Health Care Equipment & Supplies | 12.99% | 6 |
| Life Sciences Tools & Services | 10.74% | 4 |
| Distributors | 10.06% | 3 |
| Health Care Providers & Services | 6.35% | 3 |
| Technology Hardware & Equipment | 5.87% | 2 |
| Insurance | 5.80% | 3 |
| Food & Staples Retailing | 1.09% | 1 |
| # | Ticker | Name | Sector | Weight |
|---|---|---|---|---|
| 1 | XBI | SPDR SERIES TRUST | Unclassified | 14.55% |
| 2 | CAH | CARDINAL HEALTH INC | Consumer Discretionary | 3.85% |
| 3 | CALL- BSX 100 @ 75 EXP 04/17/2026 | Unclassified | 3.81% | |
| 4 | JNJ | JOHNSON & JOHNSON | Health Care | 3.71% |
| 5 | MRK | Merck & Co., Inc. | Health Care | 3.65% |
| 6 | COR | Cencora, Inc. | Consumer Discretionary | 3.58% |
| 7 | LLY | ELI LILLY & Co | Health Care | 3.49% |
| 8 | WAT | WATERS CORP /DE/ | Health Care | 3.39% |
| 9 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Health Care | 3.39% |
| 10 | ISRG | INTUITIVE SURGICAL INC | Health Care | 3.15% |
32/34 names classified · sector 81.6% of weight · industry 81.6% · mkt cap 77.4%; unclassified names shown, never dropped.
Sector is classified on each name's CURRENT fundamentals, not point-in-time — apparent sector drift can reflect the market re-rating a holding, not a manager trade. 13F is a lagged quarterly snapshot of long positions in US-listed securities only — foreign companies held via a US listing or ADR ARE included, but shares listed only on non-US exchanges (plus shorts, options and cash) are not. Latest quarter: 81.6% of the book is sector-classified (unclassified names shown, never dropped).
Classified: 77.4% of book weight (30/34 names) · unclassified 22.6%: XBI, , AZN, SNN. Size: cap 70/20/10 bands; style: value/growth composite on our own metrics — not Morningstar's model.
No contribution data for this period.
| # | Security | Shares | Value | Weight | Δ QoQ |
|---|---|---|---|---|---|
| 1 | XBISPDR SERIES TRUST | 150,000 | $19M | 14.5% | TRIM −33% |
| 2 | CAHCARDINAL HEALTH INC | 24,000 | $5M | 3.9% | TRIM −26% |
| 3 | CALL- BSX 100 @ 75 EXP 04/17/2026 | 800 | $5M | 3.8% | NEW |
| 4 | JNJJOHNSON & JOHNSON | 20,000 | $5M | 3.7% | NEW |
| 5 | MRKMERCK & CO INC | 40,000 | $5M | 3.7% | ADD 33% |
| 6 | CORCENCORA INC | 15,000 | $5M | 3.6% | TRIM −17% |
| 7 | LLYELI LILLY & CO | 5,000 | $5M | 3.5% | TRIM −29% |
| 8 | WATWATERS CORP | 15,000 | $4M | 3.4% | NEW |
| 9 | VRTXVERTEX PHARMACEUTICALS INC | 10,000 | $4M | 3.4% | TRIM −27% |
| 10 | ISRGINTUITIVE SURGICAL INC | 9,000 | $4M | 3.2% | TRIM −10% |
| 11 | AZNASTRAZENECA PLC | 20,000 | $4M | 3.0% | NEW |
| 12 | TMOTHERMO FISHER SCIENTIFIC INC | 8,000 | $4M | 3.0% | TRIM −33% |
| 13 | BSXBOSTON SCIENTIFIC CORP | 62,000 | $4M | 3.0% | TRIM −11% |
| 14 | DHRDANAHER CORP DEL | 20,000 | $4M | 2.9% | TRIM −13% |
| 15 | THCTenet Healthcare Corp. | 20,000 | $4M | 2.9% | TRIM −47% |
| 16 | GILDGILEAD SCIENCES INC | 25,000 | $3M | 2.6% | HOLD |
| 17 | HUMHUMANA INC | 20,000 | $3M | 2.6% | ADD 33% |
| 18 | MTDMETTLER TOLEDO INTERNATIONAL | 2,750 | $3M | 2.6% | TRIM −8% |
| 19 | MCKMCKESSON CORP | 4,000 | $3M | 2.6% | TRIM −56% |
| 20 | AAGILENT TECHNOLOGIES INC | 30,000 | $3M | 2.6% | TRIM −14% |
| 21 | SYKSTRYKER CORPORATION | 10,000 | $3M | 2.5% | TRIM −23% |
| 22 | ABBVABBVIE INC | 15,000 | $3M | 2.5% | TRIM −25% |
| 23 | UHSUniversal Health Svcs., Cl. B | 17,500 | $3M | 2.4% | TRIM −38% |
| 24 | REGNREGENERON PHARMACEUTICALS | 4,000 | $3M | 2.3% | NEW |
| 25 | BIOBIO RAD LABS INC | 10,000 | $3M | 2.1% | TRIM −17% |
| 26 | BIIBBIOGEN INC | 15,000 | $3M | 2.1% | TRIM −25% |
| 27 | UNHUNITEDHEALTH GROUP INC | 10,000 | $3M | 2.1% | TRIM −17% |
| 28 | GMEDGLOBUS MED INC | 30,000 | $3M | 2.0% | TRIM −25% |
| 29 | ABTABBOTT LABS | 25,000 | $3M | 1.9% | TRIM −38% |
| 30 | EWEDWARDS LIFESCIENCES CORP | 20,000 | $2M | 1.2% | TRIM −43% |
| 31 | SNNSMITH & NEPHEW PLC | 50,000 | $2M | 1.2% | TRIM −60% |
| 32 | ELVELEVANCE HEALTH INC FORMERLY | 5,000 | $1M | 1.1% | NEW |
| 33 | EHCENCOMPASS HEALTH CORP | 15,000 | $1M | 1.1% | TRIM −70% |
| 34 | CVSCVS HEALTH CORP | 20,000 | $1M | 1.1% | NEW |
| Security | 2024-Q4 | 2025-Q1 | 2025-Q2 | 2025-Q3 | 2025-Q4 | 2026-Q1 | Latest value |
|---|---|---|---|---|---|---|---|
| XBISPDR SERIES TRUST | 200K | 250K | 250K | 250K | 225K | 150K | $19M |
| CAHCARDINAL HEALTH INC | 50K | 50K | 45K | 38K | 33K | 24K | $5M |
| CALL- BSX 100 @ 75 EXP 04/17/2026 | — | — | — | — | — | 800 | $5M |
| JNJJOHNSON & JOHNSON | — | — | — | 25K | — | 20K | $5M |
| MRKMERCK & CO INC | — | — | — | — | 30K | 40K | $5M |
| CORCENCORA INC | 25K | 25K | 25K | 20K | 18K | 15K | $5M |
| LLYELI LILLY & CO | 15K | 9K | 11K | 10K | 7K | 5K | $5M |
| WATWATERS CORP | 14K | 17K | 18K | — | — | 15K | $4M |
| VRTXVERTEX PHARMACEUTICALS INC | 13K | — | — | 14K | 14K | 10K | $4M |
| ISRGINTUITIVE SURGICAL INC | — | 14K | 13K | 13K | 10K | 9K | $4M |
| AZNASTRAZENECA PLC | — | — | — | — | — | 20K | $4M |
| TMOTHERMO FISHER SCIENTIFIC INC | — | — | — | 14K | 12K | 8K | $4M |
| BSXBOSTON SCIENTIFIC CORP | 110K | 100K | 80K | 70K | 70K | 62K | $4M |
| DHRDANAHER CORP DEL | 25K | 35K | 40K | 35K | 23K | 20K | $4M |
| THCTenet Healthcare Corp. | 55K | 70K | 85K | 35K | 38K | 20K | $4M |
Shares reported each quarter by the largest current holdings. Green = added vs the prior filing of that name, red = trimmed, grey = roughly held; a dash is a quarter with no 13F on file (a gap is skipped, not read as an exit). 13F is filed up to 45 days after quarter-end. Up to 40 quarters (10 years) available — use the selector above.
Where this firm's principals came from and which firms its alumni went on to found.
